Koelblinger, Peter http://orcid.org/0000-0002-5897-2780
Funding for this research was provided by:
Paracelsus Medical University
Article History
Received: 31 January 2020
Accepted: 25 March 2020
First Online: 15 April 2020
Conflict of interest
: P. Koelblinger has received honoraria for travel support and consulting/advisory roles from Roche, Bristol Myers Squibb (BMS), Merck Sharp & Dome (MSD), Novartis, Pierre Fabre, Sanofi Aventis and Amgen outside the submitted work.